1. Home
  2. DHC vs AVXL Comparison

DHC vs AVXL Comparison

Compare DHC & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DHC
  • AVXL
  • Stock Information
  • Founded
  • DHC 1998
  • AVXL 2004
  • Country
  • DHC United States
  • AVXL United States
  • Employees
  • DHC N/A
  • AVXL N/A
  • Industry
  • DHC Real Estate Investment Trusts
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DHC Real Estate
  • AVXL Health Care
  • Exchange
  • DHC Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • DHC 757.5M
  • AVXL 710.3M
  • IPO Year
  • DHC N/A
  • AVXL N/A
  • Fundamental
  • Price
  • DHC $3.13
  • AVXL $7.53
  • Analyst Decision
  • DHC Hold
  • AVXL Strong Buy
  • Analyst Count
  • DHC 3
  • AVXL 2
  • Target Price
  • DHC $4.50
  • AVXL $44.00
  • AVG Volume (30 Days)
  • DHC 919.5K
  • AVXL 948.5K
  • Earning Date
  • DHC 05-05-2025
  • AVXL 05-13-2025
  • Dividend Yield
  • DHC 1.28%
  • AVXL N/A
  • EPS Growth
  • DHC N/A
  • AVXL N/A
  • EPS
  • DHC N/A
  • AVXL N/A
  • Revenue
  • DHC $1,511,515,000.00
  • AVXL N/A
  • Revenue This Year
  • DHC $5.25
  • AVXL N/A
  • Revenue Next Year
  • DHC $6.48
  • AVXL N/A
  • P/E Ratio
  • DHC N/A
  • AVXL N/A
  • Revenue Growth
  • DHC 5.33
  • AVXL N/A
  • 52 Week Low
  • DHC $2.00
  • AVXL $3.51
  • 52 Week High
  • DHC $4.24
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • DHC 60.27
  • AVXL 38.43
  • Support Level
  • DHC $2.96
  • AVXL $7.26
  • Resistance Level
  • DHC $3.36
  • AVXL $7.80
  • Average True Range (ATR)
  • DHC 0.15
  • AVXL 0.45
  • MACD
  • DHC -0.00
  • AVXL -0.06
  • Stochastic Oscillator
  • DHC 47.73
  • AVXL 24.34

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: